The genital warts (condyloma acuminatum) market is projected to grow from USD 2.1 billion in 2025 to USD 3.3 billion by 2035, at a CAGR of 4.8%. Preventive Treatment will dominate with a 35.5% market share, while hospital pharmacies will lead the distribution channel segment with a 42.0% share.